Ruel Jacob wrote a new post 2 years, 1 month ago
Patients Today brings the latest knowledge on promising treatment options from ESMO Congress 2022 – comprehensive evaluations and recommendations for day-to-day treatment p […]Ruel Jacob wrote a new post 2 years, 1 month ago
A study recently published in the New England Journal of Medicine created much buzz in mid-October, questioning the usefulness of colonoscopies as a screening tool for colorectal cancer (CRC).
The […]
Ruel Jacob wrote a new post 2 years, 1 month ago
DiCE participated in three exciting days of innovative and inspiring live workshops. The patient & people-centric sessions offered the chance to join small groups of like-minded individuals and co-create on a […]
Ruel Jacob wrote a new post 2 years, 2 months ago
Next year might be busier than initially expected as the European Commission is rumoured to have postponed the publication of one of the most awaited proposals – the revision of the general pharmaceutical l […]
Ruel Jacob wrote a new post 2 years, 2 months ago
Tzav Meni’a, our Associate Member, based in Israel, has recently implemented two new projects – A mentorship programme to support patients and carers and the production […]
Ruel Jacob wrote a new post 2 years, 2 months ago
At DiCE, we strongly believe in cooperation and working together, which is why it was our pleasure to join UEG at their yearly congress in Vienna this year.
DiCE was present to raise awareness and create […]
Ruel Jacob wrote a new post 2 years, 2 months ago
DiCE is pleased to announce that 4 DiCE representatives will participate in the EUPATI training programme: Cristina Vacca, from Italy; Laure Chotel, from France; Miranda […]Ruel Jacob wrote a new post 2 years, 3 months ago
Encouraging results on the use of immunotherapy for patients with deficient mismatch repair colon cancer were presented at the ESMO Congress 2022 in Paris.
Mismatch repair (MMR) genes are involved in repairing […]
Ruel Jacob wrote a new post 2 years, 3 months ago
Updated recommendation on cancer screening is based on the latest scientific advice. The new guidance updates the 2003 Council Recommendation and is one of the flagship elements of the Europe’s Beating Cancer P […]
Ruel Jacob wrote a new post 2 years, 3 months ago
UPDATE on DESTINY-Gastric02 Study: Trastuzumab Deruxtecan Continues to Demonstrate Benefit in Metastatic Gastric and Gastro-oesophageal Cancer
The DESTINY-Gastric02 study was conducted in a Western patient population (US/EU), primarily to confirm the […]Ruel Jacob wrote a new post 2 years, 3 months ago
Unresectable hepatocellular carcinoma refers to liver cancer that is not eligible for resection because of the extent of the disease. The aggressive nature of the disease reveals […]Ruel Jacob wrote a new post 2 years, 3 months ago
Leading up to October’s Liver Cancer Awareness month, DiCE attended the ILCA Annual Conference, an impactful scientific forum in the liver cancer field connecting hundreds of i […]Ruel Jacob wrote a new post 2 years, 3 months ago
Earlier this month the Czech Presidency of the EU conducted an informal meeting of EU health ministers in Prague. Ministers discussed oncology, rare diseases, vaccination (where presidency is expected to present […]
Ruel Jacob wrote a new post 2 years, 3 months ago
DiCE was invited to participate in the symposium organised by the gastroenterology and gastrointestinal Endoscopy Unit from the San Raffaele Scientific Institute in Milan to update the 28 statements for the […]
Ruel Jacob wrote a new post 2 years, 3 months ago
Digestive Cancers Europe (DiCE) and European Liver Patients’ Association (ELPA) will host a European policy event on 12 October 2022 at the European Parliament.
Bringing together experts, policymakers, pat […]Ruel Jacob wrote a new post 2 years, 3 months ago
The European Patients’ Forum (EPF) conducted a COVID-19 survey between 18 September to 18 October 2020 (the report is available here). It aimed to gather more information on the lived experience and impact of t […]
Ruel Jacob changed their profile picture 2 years, 4 months ago